GLIPR1 is significantly underexpressed in ALL when compared to normal controls [53], which is compatible with a pro-apoptotic role of GLIPR1 activation upon SB225002 treatment. The gene discussed is GLIPR1; the disease is acute lymphoblastic leukemia.